AstraZeneca PLC | AZN

Healthcare•$289.34B
Article

AstraZeneca Selects Salesforce's Agentforce Life Sciences To Power Global AI-Driven Customer Engagement

Sentiment:8
View Original
Benzinga•Dec 04, 2025•21:02
Expert OpinionPartnership/AllianceSector Analysis
Article

AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report

Sentiment:5
View Original
Benzinga•Dec 03, 2025•17:24
Expert OpinionRegulatory/PolicySector Analysis
Article

AstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026

Sentiment:8
View Original
Benzinga•Dec 03, 2025•15:27
Expert OpinionPharma/Biotech ClinicalSector Analysis
Article

The FDA Has Accepted Astrazeneca's New Drug Application For Baxdrostat For Patients With Hard-to-control Hypertension As An Add-on To Other Antihypertensive Medicines, The Prescription Drug User Fee Act Date Is Anticipated During Q2 Of 2026 Following Use Of A Priority Review Voucher

Sentiment:9
View Original
Benzinga•Dec 02, 2025•12:34
Expert OpinionPharma/Biotech ClinicalSector Analysis
Article

Trump Administration Locks In Zero Tariffs On UK Pharmaceuticals As NHS To Pay More For US Drugs

Sentiment:5
View Original
Benzinga•Dec 02, 2025•09:02
Breaking News/EventRegulatory/PolicySector Analysis